Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer

PURPOSE: The effects of chemotherapy dose intensity on survival in patients with advanced non-small-cell lung cancer (NSCLC) are poorly understood. We retrospectively analyzed dose delays/reduction, relative dose intensity (RDI), and the association between chemotherapy intensity and survival in adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, Jeffrey, Denduluri, Neelima, Patt, Debra, Jiao, Xiaolong, Morrow, Phuong Khanh, Garcia, Jacob, Barron, Richard, Lyman, Gary H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954126/
https://www.ncbi.nlm.nih.gov/pubmed/31172284
http://dx.doi.org/10.1007/s00520-019-04875-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954126/
https://www.ncbi.nlm.nih.gov/pubmed/31172284
http://dx.doi.org/10.1007/s00520-019-04875-1

Ejemplares similares